CIBC World Markets’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $76.3M | Buy |
+334,058
| New | +$76.1M | 0.37% | 42 |
|
|
2025
Q2 | $41.3M | Buy |
222,390
+9,373
| +4% | +$1.74M | 0.26% | 57 |
|
|
2025
Q1 | $44.6M | Sell |
213,017
-65,770
| -24% | -$12.8M | 0.35% | 39 |
|
|
2024
Q4 | $49.5M | Buy |
278,787
+39,070
| +16% | +$7.18M | 0.29% | 59 |
|
|
2024
Q3 | $47.3M | Buy |
239,717
+9,523
| +4% | +$1.78M | 0.34% | 52 |
|
|
2024
Q2 | $39.5M | Buy |
230,194
+49,404
| +27% | +$8.18M | 0.26% | 69 |
|
|
2024
Q1 | $32.9M | Sell |
180,790
-46,448
| -20% | -$8M | 0.22% | 79 |
|
|
2023
Q4 | $35.2M | Buy |
227,238
+61,818
| +37% | +$9.01M | 0.19% | 86 |
|
|
2023
Q3 | $24.7M | Sell |
165,420
-41,338
| -20% | -$6.07M | 0.24% | 72 |
|
|
2023
Q2 | $27.9M | Buy |
206,758
+50,128
| +32% | +$7.35M | 0.23% | 72 |
|
|
2023
Q1 | $25M | Sell |
156,630
-51,282
| -25% | -$7.84M | 0.41% | 46 |
|
|
2022
Q4 | $33.6M | Buy |
207,912
+157,576
| +313% | +$24.2M | 0.23% | 74 |
|
|
2022
Q3 | $6.76M | Buy |
+50,336
| New | +$7.22M | 0.09% | 123 |
|
|
2022
Q2 | – | Sell |
-387,204
| Closed | -$62.8M | – | 610 |
|
|
2022
Q1 | $62.8M | Sell |
387,204
-414,715
| -52% | -$60.2M | 0.49% | 40 |
|
|
2021
Q4 | $109M | Buy |
801,919
+123,171
| +18% | +$14.5M | 0.58% | 35 |
|
|
2021
Q3 | $73.2M | Buy |
678,748
+556,116
| +453% | +$63.5M | 0.5% | 35 |
|
|
2021
Q2 | $13.8M | Sell |
122,632
-45,715
| -27% | -$5.15M | 0.1% | 132 |
|
|
2021
Q1 | $18.2M | Sell |
168,347
-156,959
| -48% | -$16.8M | 0.11% | 136 |
|
|
2020
Q4 | $34.9M | Buy |
325,306
+22,122
| +7% | +$2.13M | 0.18% | 101 |
|
|
2020
Q3 | $26.6M | Sell |
303,184
-202,767
| -40% | -$19.1M | 0.26% | 95 |
|
|
2020
Q2 | $49.7M | Buy |
505,951
+397,720
| +367% | +$35M | 0.53% | 49 |
|
|
2020
Q1 | $8.25M | Sell |
108,231
-66,646
| -38% | -$5.68M | 0.11% | 166 |
|
|
2019
Q4 | $15.5M | Sell |
174,877
-358,672
| -67% | -$29.8M | 0.1% | 201 |
|
|
2019
Q3 | $40.4M | Buy |
533,549
+183,346
| +52% | +$12.6M | 0.38% | 68 |
|
|
2019
Q2 | $25.5M | Sell |
350,203
-16,396
| -4% | -$1.29M | 0.2% | 124 |
|
|
2019
Q1 | $29.5M | Sell |
366,599
-121,260
| -25% | -$9.92M | 0.24% | 91 |
|
|
2018
Q4 | $45M | Sell |
487,859
-129,715
| -21% | -$11.4M | 0.42% | 65 |
|
|
2018
Q3 | $58.4M | Sell |
617,574
-650,349
| -51% | -$61.7M | 0.5% | 54 |
|
|
2018
Q2 | $117M | Buy |
1,267,923
+835,978
| +194% | +$81.6M | 1.01% | 12 |
|
|
2018
Q1 | $40.9M | Buy |
431,945
+77,231
| +22% | +$8.48M | 0.43% | 47 |
|
|
2017
Q4 | $34.3M | Buy |
354,714
+109,730
| +45% | +$10.3M | 0.25% | 88 |
|
|
2017
Q3 | $21.8M | Buy |
244,984
+20,085
| +9% | +$1.53M | 0.21% | 104 |
|
|
2017
Q2 | $16.3M | Buy |
224,899
+58,448
| +35% | +$3.93M | 0.17% | 148 |
|
|
2017
Q1 | $10.8M | Buy |
166,451
+54,906
| +49% | +$3.45M | 0.09% | 174 |
|
|
2016
Q4 | $6.99M | Sell |
111,545
-148,459
| -57% | -$9.06M | 0.07% | 194 |
|
|
2016
Q3 | $16.4M | Buy |
+260,004
| New | +$16.8M | 0.31% | 83 |
|
|
2014
Q1 | – | Sell |
-18,863
| Closed | -$996K | – | 36 |
|
|
2013
Q4 | $996K | Buy |
+18,863
| New | +$927K | 0.49% | 39 |
|
Other funds holding ABBV
CIBC World Markets's ABBV Position: Q4 2025 in Review
CIBC World Markets opened a new position in AbbVie (ABBV) in Q4 2025: 334,058 shares worth $76.3M. The stake represents 0.37% of the portfolio and ranks #42 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ABBV as recently as Q2 2025.
CIBC World Markets first reported a position in ABBV in Q4 2013 and has held it in 37 quarters since. The position peaked at $117M in Q2 2018. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- CIBC World Markets held 334,058 shares of AbbVie worth $76.3M as of Q4 2025.
- AbbVie was a new CIBC World Markets position in Q4 2025.
- AbbVie made up 0.37% of CIBC World Markets's portfolio in Q4 2025, its #42 holding.
- CIBC World Markets first reported a position in AbbVie in Q4 2013 and has held it in 37 quarters since.
- CIBC World Markets's AbbVie position peaked at $117M in Q2 2018.
- 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.